Monoclonal Antibody-Based Therapy for Eosinophilic Oesophagitis
Author:
Open Access
- 1 December 2016
- journal article
- Published by European Medical Group in EMJ. Gastroenterology
- Vol. 5 (1) , 125-129
Abstract
Eosinophilic oesophagitis is an inflammatory condition associated with marked eosinophil accumulation in the mucosal tissues of the oesophagus.Keywords
This publication has 49 references indexed in Scilit:
- Eosinophils: changing perspectives in health and diseaseNature Reviews Immunology, 2012
- Esophageal functional impairments in experimental eosinophilic esophagitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Involvement of mast cells in eosinophilic esophagitisJournal of Allergy and Clinical Immunology, 2010
- Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trialGut, 2009
- Eosinophilic gastroenteritis: a reviewJournal of Gastroenterology, 2008
- Eosinophilic esophagitis: management and pharmacotherapyExpert Opinion on Pharmacotherapy, 2008
- Enhanced soluble interleukin‐5 receptor alpha expression in nasal polyposisAllergy, 2003
- Advances in the Immunobiology of Eosinophils and Their Role in DiseaseCritical Reviews in Clinical Laboratory Sciences, 1999
- Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.Journal of Experimental Medicine, 1996
- Evaluation of Airway Hyperreactivity in lnterleukin-5 Transgenic MiceInternational Archives of Allergy and Immunology, 1995